Aditi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.12 Cr
as on 11-12-2024
- Company Age 39 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.17 Cr
as on 11-12-2024
- Revenue 39.26%
(FY 2022)
- Profit 204.59%
(FY 2022)
- Ebitda 38.56%
(FY 2022)
- Net Worth 11.23%
(FY 2022)
- Total Assets 15.05%
(FY 2022)
About Aditi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.12 Cr.
The company has closed loans amounting to ₹1.17 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Atul Bakshi and Jemini Bakshi serve as directors at the Company.
- CIN/LLPIN
U24239PN1985PTC036140
- Company No.
036140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 1985
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aditi Pharmaceuticals Pvt Ltd offer?
Aditi Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Aditi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Bakshi  | Managing Director | 07-May-1985 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jemini Bakshi | Director | 03-Oct-2007 | Current |
Financial Performance of Aditi Pharmaceuticals.
Aditi Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 39.26% increase. The company also saw a substantial improvement in profitability, with a 204.59% increase in profit. The company's net worth Soared by an impressive increase of 11.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aditi Pharmaceuticals?
In 2022, Aditi Pharmaceuticals had a public holding of 11.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Maharashtra State Financial Corporation Creation Date: 01 Nov 2000 | ₹3.15 M | Satisfied |
Maharashtra State Financial Corporation Creation Date: 31 Mar 1995 | ₹2.00 M | Satisfied |
Maharashtra State Financial Corporation Creation Date: 04 Jul 1994 | ₹3.00 M | Satisfied |
How Many Employees Work at Aditi Pharmaceuticals?
Aditi Pharmaceuticals has a workforce of 103 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
